AKT1 and juvenile myelomonocytic leukemia: Moreover, activation of the Lyn/PI3K/Akt pathway was found to be involved in the survival and proliferation of myeloma cells and resistance to apoptosis in juvenile myelomonocytic leukemia (JMML)58,59.